Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 07, 2015 08:30 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. Announces Investigator Initiated Clinical Trial of Vayarin(R) in Managing ADHD in Children With Epilepsy

MIGDAL HA'EMEQ, Israel, July 7, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) ("Enyzmotec" or the "Company"), a developer, manufacturer and marketer of innovative bio-active lipid-based...
June 11, 2015 16:05 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. Announces Annual General Meeting of Shareholders

MIGDAL HA'EMEQ, Israel, June 11, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) (the "Company"), today announced that it will hold an Annual General Meeting of Shareholders on Wednesday, July...
May 20, 2015 08:30 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. to Participate in the Jefferies 2015 Global Healthcare Conference

MIGDAL HA'EMEQ, Israel, May 20, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) ("Enzymotec" or the "Company"), a developer, manufacturer and marketer of innovative bio-active lipid ingredients,...
May 07, 2015 07:30 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. Reports First Quarter 2015 Unaudited Financial Results

MIGDAL HA'EMEQ, Israel, May 7, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, today reported financial...
April 30, 2015 08:30 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. Announces Positive Results Comparing Vayarol(R) to Ethyl Esters of Omega-3

MIGDAL HA'EMEQ, Israel, April 30, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd., (Nasdaq:ENZY) ("Enzymotec" or the "Company"), a developer, manufacturer and marketer of innovative bio-active lipid based...
April 23, 2015 08:30 ET | Source: Enzymotec Ltd.

Enzymotec to Report First Quarter 2015 Financial Results

MIGDAL HA'EMEQ, Israel, April 23, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, today announced that the...
March 24, 2015 09:23 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. Reports a Decision of the U.S. Patent and Trademark Office

MIGDAL HA'EMEQ, Israel, March 24, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) ("Enzymotec" or the "Company"), a developer, manufacturer and marketer of innovative bio-active lipid...
March 13, 2015 09:47 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. Granted New Patents in the United States and Australia Relevant to Phospholipid-Based Products

MIGDAL HA'EMEQ, Israel, March 13, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) ("Enzymotec" or the "Company"), a developer, manufacturer and marketer of innovative bio-active lipid...
February 18, 2015 07:30 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. Reports Fourth Quarter and Full Year 2014 Unaudited Financial Results

MIGDAL HA'EMEQ, Israel, Feb. 18, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients and medical foods, today...
February 13, 2015 08:30 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. Announces the Appointment of Holger Liepmann to Its Board of Directors

MIGDAL HA'EMEQ, Israel, Feb. 13, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) (the "Company"), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, announced...